ET HEALTH
DEAD

Serial Number

88907218

Owner

Access Medical Systems

Attorney

Andrew T. Pettit

Filing Date

May 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ET HEALTH Trademark

Serial Number: 88907218

ET HEALTH is a trademark filed by Access Medical Systems on May 8, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Access Medical Systems (7 trademarks)

1455 Adams Dr 1322
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

May 8, 2020

Registration Date

Not Registered

Published for Opposition

November 15, 2022

Goods & Services

Optical instruments for measuring a reaction by monitoring changes in the reflection of light, namely, interferometers; laboratory instruments in the nature of interferometers for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development; probes for scientific, research, or diagnostic purposes, not for medical or veterinary purposes; probes for scientific purposes, namely, probes to which biomolecules bind over the course of a scientific, research, or diagnostic procedure; interferometric sensors; probes for scientific purposes, namely, probes to which biomolecules bind during a scientific, research, or diagnostic procedure; probes for label-free analysis of assays being probes for scientific purposes; regenerable probes for scientific purpose, namely, probes for use in multiple scientific, research, or diagnostic procedures; downloadable computer software for scientific, research, or diagnostic analysis of interferometric measurements; downloadable computer software for scientific, research, or diagnostic analysis, namely, for performing antibody titer determination and isotyping; laboratory apparatus, namely, immunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; laboratory apparatus, namely, automated immunoassay analyzers for scientific, research, or diagnostic use, not for medical purposes

Diagnostic reagents for medical use; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes

Reagents for reacting with biomolecules for scientific use; reagents for scientific use; reagents for reacting with biomolecules for research use; reagents for research use; diagnostic reagents for scientific research use; diagnostic reagents, buffers, and preparations, except for medical and veterinary use; biochemical reagents used for non-medical purposes for detecting and/or analyzing antigens, antibodies, proteins, ligands, or nucleotides; laboratory chemicals, namely, antibody reagents used for the detection of antigens or antibodies in liquid, cell, and tissue analysis for in vitro diagnostic use; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes

Medical instruments, namely, diagnostic instruments for the analysis of body fluids through the measuring of light interference; medical diagnostic instruments for the analysis of body fluids through interferometry; medical diagnostic instruments for the analysis of biomolecules through interferometry; medical diagnostic tool in the nature of medical instruments for analyzing body fluids for investigating scientific questions and conducting tests; interferometers for medical use; interferometric sensors for medical use; probes for detecting and/or analyzing molecules in protein or nucleotide arrays for medical purposes; probes to which biomolecules bind during a medical procedure; probes for medical purposes for label-free analysis of assays; regenerable probes for use in multiple medical procedures; diagnostic kits consisting primarily of antibodies and reagents for use in disease testing for medical purposes; medical diagnostic apparatus, namely, immunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; medical diagnostic apparatus, namely, automated immunoassay analyzers for medical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 12, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 12, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 10, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 10, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 10, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 10, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 11, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 23, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 23, 2022 GNFR
FINAL REFUSAL WRITTEN
Aug 23, 2022 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 29, 2022 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 10, 2022 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 13, 2022 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 27, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 10, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2020 NWOS
NEW APPLICATION ENTERED
May 12, 2020 NWAP